| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
6 companies
Jean Jacques Bienaime is Director at BMRN and has filed Form 4s across 6 companies. From September 2015 to August 2026, the filings on record show 21 open-market purchases and 123 sales. Jean Jacques Bienaime's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $31.2M at current prices.
Historically, Jean Jacques Bienaime's trades have earned a middling insider score of 68/100 across 67 rated trades. Over a 12-month horizon, 64.3% of those trades were profitable, with an average 12-month return of +8.5%.
The biggest single holding is BMRN (~$26.4M) as Director. The BMRN filings lean toward selling, a net 2,115,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 9, 2020 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 10,000 | $79.06 | $790,600.00 | -3.2% | |
| Mar 9, 2020 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 10,000 | $89.52 | $895,200.00 | -3.3% | |
| Feb 3, 2020 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 10,000 | $83.50 | $835,000.00 | -3.0% | |
| Jan 14, 2020 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 8,000 | $87.95 | $703,600.00 | -2.4% | |
| Jan 8, 2020 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 7,000 | $84.72 | $593,060.00 | -2.1% | |
| Dec 27, 2019 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 8,000 | $86.26 | $690,090.00 | -2.4% | |
| Nov 22, 2019 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 10,000 | $77.60 | $776,000.00 | -3.0% | |
| Oct 25, 2019 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 5,000 | $69.55 | $347,750.00 | -1.5% | |
| Aug 2, 2019 | INCY Incyte Corp | Director | Sell | 1,724 | $85.07 | $146,653.73 | -19.6% | |
| May 10, 2019 | BMRN Biomarin Pharmaceutical Inc | Chief Executive Officer | Sale+OE | 10,000 | $82.52 | $825,193.00 | -3.0% |